González-Beiras C et al. |
Single-Dose Azithromycin for the Treatment of Haemophilus ducreyi Skin Ulcers in Papua New Guinea. |
2017 |
Clin. Infect. Dis. |
pmid:29020192
|
Lu Y et al. |
Antibiotics Promote Escherichia coli-Pseudomonas aeruginosa Conjugation through Inhibiting Quorum Sensing. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28993333
|
Agarwal P et al. |
susceptibility of Indian isolates to different antimalarial drugs & antibiotics. |
2017 |
Indian J. Med. Res. |
pmid:29512604
|
Stoney RJ et al. |
Travelers' Diarrhea and Other Gastrointestinal Symptoms Among Boston-Area International Travelers. |
2017 |
Am. J. Trop. Med. Hyg. |
pmid:28719282
|
Harper LM et al. |
Economic Evaluation of Adjunctive Azithromycin Prophylaxis for Cesarean Delivery. |
2017 |
Obstet Gynecol |
pmid:28697108
|
Fan LC et al. |
Macrolides protect against infection via inhibition of inflammasomes. |
2017 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:28684545
|
Wang Y et al. |
Synthesis and antibacterial activity of novel 4″-O-(1-aralkyl-1,2,3-triazol-4-methyl-carbamoyl) azithromycin analogs. |
2017 |
Bioorg. Med. Chem. Lett. |
pmid:28655423
|
Kirk SK et al. |
Efficacy of Azithromycin and Compounded Atovaquone for Treatment of Babesia gibsoni in Dogs. |
2017 |
J. Vet. Intern. Med. |
pmid:28625019
|
Vajpayee S et al. |
Scrub typhus causing neonatal hepatitis with acute liver failure-A case series. |
2017 |
Indian J Gastroenterol |
pmid:28612320
|
Kimura S et al. |
Azithromycin Modulates 3',5'-cyclic Diguanylic Acid Signaling in Pseudomonas aeruginosa. |
2017 |
J. Infect. Chemother. |
pmid:28579350
|
Riddle MS et al. |
Trial Evaluating Ambulatory Therapy of Travelers' Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide. |
2017 |
Clin. Infect. Dis. |
pmid:29029033
|
Alchakaki A et al. |
Which patients with respiratory disease need long-term azithromycin? |
2017 |
Cleve Clin J Med |
pmid:28985171
|
Senilă S et al. |
Infliximab-induced acne and acute localized exanthematous pustulosis: Case report. |
2017 |
Dermatol Ther |
pmid:28976720
|
Giguère S et al. |
Antimicrobial Resistance in . |
2017 |
Microbiol Spectr |
pmid:29052538
|
Koeva M et al. |
An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923873
|
Oluwalana C et al. |
Azithromycin in Labor Lowers Clinical Infections in Mothers and Newborns: A Double-Blind Trial. |
2017 |
Pediatrics |
pmid:28130432
|
Gerber JS and Zaoutis TE |
Azithromycin Prophylaxis for Laboring Mothers. |
2017 |
Pediatrics |
pmid:28130431
|
Cogen JD et al. |
Characterization of Inpatient Cystic Fibrosis Pulmonary Exacerbations. |
2017 |
Pediatrics |
pmid:28126911
|
Cramer CL et al. |
Immunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician. |
2017 |
Postgrad Med |
pmid:28116959
|
Liu D et al. |
Mycoplasma-associated multidrug resistance of hepatocarcinoma cells requires the interaction of P37 and Annexin A2. |
2017 |
PLoS ONE |
pmid:28976984
|
Kibuule D et al. |
An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia's public sector: Findings and therapeutic implications. |
2017 |
Int. J. Clin. Pract. |
pmid:28090718
|
Varano GP et al. |
Post-ischemic treatment with azithromycin protects ganglion cells against retinal ischemia/reperfusion injury in the rat. |
2017 |
Mol. Vis. |
pmid:29296071
|
Pokharel S et al. |
Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial. |
2017 |
Trials |
pmid:28969659
|
Brown JD et al. |
Shigella species epidemiology and antimicrobial susceptibility: the implications of emerging azithromycin resistance for guiding treatment, guidelines and breakpoints. |
2017 |
J. Antimicrob. Chemother. |
pmid:28961759
|
Jacobsson S et al. |
Activity of the Novel Pleuromutilin Lefamulin (BC-3781) and Effect of Efflux Pump Inactivation on Multidrug-Resistant and Extensively Drug-Resistant Neisseria gonorrhoeae. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28893785
|
Gensel JC et al. |
Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment. |
2017 |
Sci Rep |
pmid:28057928
|
Sutton SS |
Is cardiovascular risk a concern when prescribing azithromycin? |
2017 |
JAAPA |
pmid:28033168
|
Shapiro ED and Wormser GP |
Prophylaxis with topical azithromycin against Lyme borreliosis. |
2017 |
Lancet Infect Dis |
pmid:28007427
|
Seyama S et al. |
Emergence and molecular characterization of Haemophilus influenzae harbouring mef(A). |
2017 |
J. Antimicrob. Chemother. |
pmid:27999037
|
Haque F et al. |
Evaluation of a Smartphone Decision-Support Tool for Diarrheal Disease Management in a Resource-Limited Setting. |
2017 |
PLoS Negl Trop Dis |
pmid:28103233
|
Bulman ZP et al. |
Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28096154
|
Wind CM et al. |
Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015. |
2017 |
Euro Surveill. |
pmid:28079519
|
Tita ATN et al. |
Adjunctive Azithromycin Prophylaxis for Cesarean Delivery. |
2017 |
N. Engl. J. Med. |
pmid:28076707
|
Idkaidek N et al. |
Saliva Versus Plasma Bioequivalence of Azithromycin in Humans: Validation of Class I Drugs of the Salivary Excretion Classification System. |
2017 |
Drugs R D |
pmid:28074334
|
Gomes C et al. |
Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin. |
2017 |
Crit. Rev. Microbiol. |
pmid:27786586
|
Kwakye-Maclean C et al. |
A Single Dose Oral Azithromycin versus Intramuscular Benzathine Penicillin for the Treatment of Yaws-A Randomized Non Inferiority Trial in Ghana. |
2017 |
PLoS Negl Trop Dis |
pmid:28072863
|
Fu L et al. |
Toxicity of 13 different antibiotics towards freshwater green algae Pseudokirchneriella subcapitata and their modes of action. |
2017 |
Chemosphere |
pmid:27783962
|
Descours G et al. |
Ribosomal Mutations Conferring Macrolide Resistance in Legionella pneumophila. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28069647
|
Björnelius E et al. |
macrolide resistance in Stockholm, Sweden. |
2017 |
Sex Transm Infect |
pmid:27502694
|
O'Rourke VJ |
Azithromycin as an adjunct to non-surgical periodontal therapy: a systematic review. |
2017 |
Aust Dent J |
pmid:27492140
|
Barberá MJ et al. |
Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance: Prevalence and Risk Factors Among a 2013-2014 Cohort of Patients in Barcelona, Spain. |
2017 |
Sex Transm Dis |
pmid:28703723
|
Brusselle G and Pavord I |
Azithromycin in uncontrolled asthma. |
2017 |
Lancet |
pmid:28687412
|
Xiao Z et al. |
Comparison of the ameliorative effects of Qingfei Tongluo formula and azithromycin on Mycoplasma pneumoniae pneumonia. |
2017 |
J Nat Med |
pmid:28664473
|
Atkinson CT et al. |
Expression of acquired macrolide resistance genes in Haemophilus influenzae. |
2017 |
J. Antimicrob. Chemother. |
pmid:28961896
|
Lendermon EA et al. |
Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation. |
2017 |
Respir. Res. |
pmid:28659178
|
Turner KM et al. |
Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of : a modelling study. |
2017 |
BMJ Open |
pmid:28615273
|
Fohner AE et al. |
PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics. |
2017 |
Pharmacogenet. Genomics |
pmid:28146011
|
Marks M et al. |
Mathematical Modeling of Programmatic Requirements for Yaws Eradication. |
2017 |
Emerging Infect. Dis. |
pmid:27983500
|
Zhang C et al. |
Decreased Susceptibility to Azithromycin Among Clinical Shigella Isolates from China. |
2017 |
Microb. Drug Resist. |
pmid:27841958
|
Segal LN et al. |
Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung. |
2017 |
Thorax |
pmid:27486204
|